DermBiont
Dr. Robert Brucker leads research efforts at DermBiont.
He was previously a Rowland Fellow at Harvard University where he ran a research program on applied microbiomes, host-microbe coevolution, and ecotoxicology.
Robert has helped design and conduct over ten clinical microbiome studies. Dr. Brucker has dozens of publications related to host-microbe associations (published in journals Nature ISME, Science, and Nature Communications), including experimental probiotic trials for antifungal activity.
He has fifteen years of genetics, microbiology, microbial ecology, and applied microbiota experience. Rob received his B.S. in Biology from the University of Mount Union and earned a PhD in Biomedical Sciences from Vanderbilt University.
DermBiont
DermBiont’s mission is to become the world’s leading precision dermatology company developing targeted topical therapeutics that treat, cure, and prevent diseases.